Jill Rasmussen

Biography

Jill obtained her medical degree from Manchester and has held senior positions in the Pharma Industry in Europe and the US including positions with the Wellcome Foundation, Lundbeck Ltd, UK, SmithKline Beecham, Duphar BV (The Netherlands, now Solvay Pharmaceuticals) & Kali-Duphar Inc (U.S.A., now also part of Solvay). During her time in the industry Jill has worked in the following therapeutic areas, affective disorders (depression, dysthymia); anxiety and phobic states (generalised anxiety disorder, panic disorder with and without agoraphobia, social anxiety disorder), Obsessive Compulsive Disorder; psychoses (schizophrenia, bipolar disorder); sleep and circadian rhythm disorders; dementia (Alzheimer’s, Lewy Body, vascular); Neurological disorders (Parkinson's disease, epilepsy, migraine, pain). Jill has also gained experience as a Senior Medical Assessor with the UK regulatory agency the MHRA (formerly the MCA). In 1999 in recognition of her services to CNS research, she was made a Fellow of the Faculty of Pharmaceutical Medicine. From 2002 to 2004, she was the Director of the UK National Neuroscience Institute. In addition to her work in ProPharma, Jill maintains a part-time clinical commitment as a community specialist in psychiatry and neurology. She is a member of major international psychopharmacology and neurology organisations and attends relevant conferences to remain at the cutting edge of both the therapeutic areas and developments in worldwide clinical trial methodology and regulatory strategy. From 2002 to 2004, Jill was a member of the British Association of Psychopharmacology Council. Since 2004 she has been elected to the Board of the International Psychogeriatric Association.

Research Interest

..